International bonds: Teva Pharmaceutical Industries, 1.50% 15jun2012, USD (US88166BAB62, 88166BAB6)
| Status | Country of risk | Maturity (option) | Amount
i This field shows outstanding face value amount for outstanding bonds
| Issue ratings (M/S&P/F) |
|---|---|---|---|---|
| redeemed | Israel | **/**/**** | 1,000,000,000 USD | ***/***/*** |
×
Available to subscribers "Price Center NRD". Order paid / trial access .
×
Yield calculation
×
Registration required. Please log in or fill in the registration form.
Issue information
| Borrower | Teva Pharmaceutical Industries |
| SPV / Issuer | Teva Pharmaceutical Finance III LLC |
| Bond type | Coupon bonds |
| Placement method | Open subscription |
| Par amount, integral multiple | 1,000 USD |
| Nominal of international bonds | 1,000 USD |
| Minimum settlement amount | 2,000 USD |
| Outstanding principal amount | 0 USD |
| Amount | 1,000,000,000 USD |
| Amount Outstanding | 0 USD |
| Placement date | **/**/**** |
| Maturity date | **/**/**** |
| Floating rate | No |
| Coupon Rate | *.*% |
| Current coupon rate | 1.5% |
| Day count fraction | *** |
| Coupon frequency | 2 time(s) per year |
| Interest accrual date | **/**/**** |
| Listing | SIX |
Related issues
- Teva Pharmaceutical Industries, 3.15% 1oct2026, USD
- Teva Pharmaceutical Industries, 2.8% 21jul2023, USD
- Teva Pharmaceutical Industries, 2.2% 21jul2021, USD
- Teva Pharmaceutical Industries, 4.1% 1oct2046, USD
- Teva Pharmaceutical Industries, 2.95% 18dec2022, USD
×
Registration required. Please log in or fill in the registration form.
Cbonds ValuationiIndicative bond and international bond quotes by Cbonds are calculated based on the methodology. The end result of the methodology is a single end-of-day Cbonds quote, which is based on bid and ask data of various trading floors and contributors working with this asset. :
Indicative bond and international bond quotes by Cbonds are calculated based on the methodology. The end result of the methodology is a single end-of-day Cbonds quote, which is based on bid and ask data of various trading floors and contributors working with this asset.
Bond classification
| Subordinated | |
| Sinkable bond | |
| Perpetual | |
| Convertible | |
| Structured product | |
| Restructuring | |
| Securitization | |
| Mortgage bonds | |
| Trace-eligible |
| Covered | |
| Foreign bonds | |
| CDO | |
| Sukuk | |
| Retail bonds | |
| Supranational bond issues | |
| Green bonds | |
| Non-Marketable Securities |
Identifiers
| ISIN / ISIN RegS | US88166BAB62 |
| CUSIP / CUSIP RegS | 88166BAB6 |
| Common Code / Common Code RegS | 051990048 |
| CFI / CFI RegS | DBFGGR |
| FIGI / FIGI RegS | BBG0000X6K96 |
| Ticker | TEVA 1.5 06/15/12 |
Primary placement
| Issuer rating on issue date (M/S&P/F) | ***/***/*** |
| Placement | **/**/**** |
| Initial issue price (yield) | **.***% ( - ) |
| Spread over US Treasuries, bp | **.* |
Participants
| Bookrunner: | Credit Suisse, Goldman Sachs, Morgan Stanley |
Additional information
Payment schedule
*****
| Coupon date | Coupon, % | Coupon payment amount, USD | Redemption of principal, USD | ||
|---|---|---|---|---|---|
| Show previous | |||||
| 1 | **/**/**** | *.* | ** | ||
| 2 | **/**/**** | *.* | ** | ||
| 3 | **/**/**** | *.* | ** | ||
| 4 | **/**/**** | *.* | ** | *,*** | |
| Show following | |||||
Issue ratings
Teva Pharmaceutical Industries, 1.50% 15jun2012, USD
| Rating Agency | Rating / Outlook | Scale | Date |
|---|---|---|---|
| Moody's Investors Service | ***/*** | LT- foreign currency | 06/15/2012 |
Issuer ratings
Teva Pharmaceutical Industries
| Rating Agency | Rating / Outlook | Scale | Date |
|---|---|---|---|
| Fitch Ratings | ***/*** | LT Int. Scale (foreign curr.) | 06/07/2019 |
| Moody's Investors Service | ***/*** | LT- local currency | 01/12/2018 |
| Moody's Investors Service | ***/*** | LT- foreign currency | 08/14/2019 |
| S&P Global Ratings | ***/*** | Foreign Currency LT | 10/24/2019 |
| S&P Global Ratings | ***/*** | Local Currency LT | 10/24/2019 |
